IASLC Announces New JTO CRR Editor-in-Chief

Mesothelioma Pioneer Delivers 2023 Heine H. Hansen Keynote Lecture

… honored for his significant contributions to lung cancer research during the 2023 European Lung Cancer Congress. … …

Final Poster Networking Reception Tonight

… this evening to talk with poster presenters about their research. … Final Poster Networking Reception Tonight … Erin …

Recurrence Remains a Risk Even for Patients Diagnosed via Screening

… patients when guidelines and protocols vary and more research is needed. … Recurrence Remains a Risk Even for …

US FDA Grants Breakthrough Therapy Designation for Novel TKI Targeting HER2, EGFR

… In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited …

Step it Up at WCLC 2025 in Barcelona

… audio. Participants can also support the IASLC’s future research initiatives and earn additional points by donating to …

More Than Ever, Surgeons Must Collaborate to Ensure Patients Receive Appropriate Care

… oncological surgery. Finally, oncology is the most active research field globally. constantly evolving treatment methods … summary, because of significant progress in oncological research for NSCLC, and because surgery is an early and …

2024 IASLC Academy to Once Again Compete in Amazing Case Race

Antibody Drug Conjugates: Diamonds in the Rough?

… the blood brain barrier, underscoring the need for more research into this phenomenon All in all, the future looks … TPS ≥50%: phase 3 KEYNOTE-D46/EVOKE-03 study. Cancer Research. 2023;83(8_Supplement):CT067-CT067. …

Recurrence Remains a Risk Even for Patients Diagnosed via Screening

… immunotherapy and improved novel and targeted therapies. Research evaluating the survival benefit of early recurrence …

Artificial Intelligence in Thoracic Radiation Oncology: Treatment, Challenges, and Future Directions

… such as immunotherapy. Additionally, while prior AI research in radiation oncology has mostly focused on the …